20 completed, 4 recruiting, 4 terminated, 1 not yet recruiting. 10 Phase 3, 5 Phase 2, 3 Not applicable, 3 Phase 1, 2 Phase 4.
Follow follitropin delta: new trials by email Literature Review of follitropin delta trials Research Report on follitropin delta
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Embryo QUAlity in Ovarian Stimulation With hMG. 10 mcg of follitropin-delta + 150 of hMG, 5 mcg of follitropin-delta + 225 of hMG - Infertility | Phase 4 | Not yet recruiting | Fundacion Dexeus | 240 | 2026-09-01 | 2026-07-08 |
| Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE) REKOVELLE (Follitropin Delta) - Infertility, Insemination | Phase 2 | Recruiting | Centre Hospitalier Intercommunal Creteil | 80 | 2025-12-17 | 2026-04-08 |
| Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST) Human chorionic gonadotropin (hCG), Follitropin delta, Triptorelin - Low Ovarian Reserve, Poor Ovarian Response | Phase 3 | Recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 126 | 2024-09-17 | 2026-09-11 |
| An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation. FE 999302, Follitropin delta, Placebo FE 999302 - Infertility | Phase 1 | Terminated | Ferring Pharmaceuticals | 106 | 2024-07-15 | 2026-03-30 |
| An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation Follitropin delta, FE999302, FE999302 Placebo - Fertility | Phase 1 | Terminated | Ferring Pharmaceuticals | 310 | 2024-06-14 | 2026-03-30 |
| A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China FE 999049, GONAL-F - Infertility, Female | Phase 3 | Completed | Ferring Pharmaceuticals | 301 | 2024-03-29 | 2026-02-12 |
| INtensity of OVarian Stimualtion and Euploid Embryos Follitropin-delta (Rekovelle) 20 mcg/day from D1, Follitropin-delta (Rekovelle) 15 mcg/day from D1 - Fertility | Phase 4 | Recruiting | Fundación Santiago Dexeus Font | 110 | 2023-12-12 | 2026-09-08 |
| Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin Follitropin delta - IVF, Infertility | Completed | Clinique Ovo | 118 | 2023-05-20 | 2025-12-09 | |
| Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone Follitropin delta (Rekovelle), Duphaston, GnRH agonist (Gonapeptyl) - Oocyte Donors, Oocyte Donation | Not applicable | Unknown | CRG UZ Brussel | 50 | 2023-04-01 | 2024-02-08 |
| Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice REKOVELLE® - Controlled Ovarian Stimulation | Completed | Ferring Pharmaceuticals | 201 | 2022-08-28 | 2025-10-02 | |
| A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM) FE 999049, Placebo - Male Idiopathic Infertility | Phase 2 | Terminated | Ferring Pharmaceuticals | 4 | 2022-08-16 | 2026-08-28 |
| A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation REKOVELLE (Follitropin Delta), GONAL-F (Follitropin Alfa) - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 302 | 2022-07-15 | 2025-04-02 |
| Real-world Evidence on Follitropin Delta Individual Dosing Follitropin delta - Infertility, Sterility | Recruiting | University of Luebeck | 850 | 2021-12-08 | 2025-03-30 | |
| Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women Follitropin Delta (FE 999049), Follitropin Alfa (GONAL-F) - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 220 | 2021-12-03 | 2025-01-24 |
| Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders Follitropin Alfa, Follitropin delta, human menopausal gonadotropin - Infertility, Ovarian Dysfunction | Not applicable | Completed | Peter Kovacs MD | 190 | 2021-12-02 | 2024-12-13 |
| Higher Dose of Rekovelle in Oocyte Donors Follitropin Delta, Recombinant - IVF | Phase 2 | Completed | IVI Madrid | 40 | 2021-09-28 | 2022-11-14 |
| Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice Follitropin Delta - Controlled Ovarian Stimulation | Completed | Ferring Pharmaceuticals | 250 | 2020-06-17 | 2021-12-14 | |
| Personalized Insemination Treatment Study Follitropin delta - Infertility, Intrauterine Insemination | Phase 2 | Completed | Clinique Ovo | 110 | 2020-01-09 | 2022-09-13 |
| Follitropin Delta Versus Follitropin Alfa in Indonesian Women Undergoing IUI Follitropin Delta, Recombinant, Follitropin Alfa (GONAL-F) - Infertility, Ovulation Induction | Completed | Stella Maris Women and Children Hospital | 228 | 2020-01-01 | 2026-09-03 | |
| Rekovelle PK Trial in Chinese Women Follitropin Delta - Infertility | Phase 1 | Completed | Ferring Pharmaceuticals | 24 | 2019-06-23 | 2023-02-14 |
Showing 20 of 30. Sign in to see all of them.
Infertility (15) · Infertility, Female (2) · Ovarian Hyperstimulation Syndrome (1)
Ferring Pharmaceuticals (18) · Clinique Ovo (2) · CRG UZ Brussel (1) · Centre Hospitalier Intercommunal Creteil (1) · Dr François Bissonnette (1) · Fundacion Dexeus (1) · Fundación Santiago Dexeus Font (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · IVI Madrid (1) · Peter Kovacs MD (1) · Stella Maris Women and Children Hospital (1) · University of Luebeck (1)
Spain (12) · Belgium (8) · Denmark (8) · Canada (6) · Czechia (5) · France (5) · Italy (5) · United Kingdom (5) · China (3) · Germany (3) · Norway (3) · Poland (3) · United States (3) · Austria (2) · Brazil (2)
Jacques Kadoch, MD (2) · Al Yuzpe, MD (1) · Cesar Lizan Tudela (1) · Christophe Blockeel, Prof, MD (1) · Clifford Librach, MD (1) · Nicolas Chevalier (1) · Nikolaos P Polyzos, MD, PhD (1) · Peter Kovacs, MD (1) · Tom Hannam, MD (1)
PMID 37156263, PMID 27912901, PMID 30801744, PMID 32819842, PMID 34254211, PMID 34799275, PMID 40714031, PMID 17007663, PMID 19136673, PMID 20362973, PMID 21505041, PMID 21558332, PMID 23312225, PMID 23507133, PMID 24077980, PMID 25362088, PMID 26921622, PMID 29121326, PMID 29935660, PMID 30196963, PMID 30594482, PMID 31838515, PMID 32211953, PMID 33267959, PMID 33272623, PMID 33280722, PMID 33722477, PMID 34179971, PMID 36195924, PMID 36478528, PMID 36619578, PMID 37194068, PMID 37835035, PMID 40633120, PMID 40979710
2023 (3), 2017 (1), 2025 (1)